Drug intelligence / Profile preview

Dapatech

Development stage
Unknown
Lead developer
Cytech Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

Dapatech is a branded generic formulation of dapagliflozin, an oral antidiabetic medication developed and marketed by Cytech Pharma in India. As a sodium-glucose cotransporter 2 (SGLT2) inhibitor, it works by blocking the SGLT2 protein in the proximal renal tubules of the kidney. This action prevents the reabsorption of filtered glucose back into the bloodstream, promoting its excretion through urine. Dapatech is primarily indicated for the treatment of type 2 diabetes mellitus to improve glycemic control. Beyond its glucose-lowering effects, it is also recognized for its role in reducing the risk of cardiovascular complications, such as heart failure, and slowing the progression of chronic kidney disease, which are established class indications for SGLT2 inhibitors.

Brand names
DapatechDapatech-10Dapatech10Dapatech 10
Other names
dapagliflozin
02

Targets

SGLT2 (Sodium-glucose cotransporter protein subunit 2)

Beyond the preview

Go deeper on Dapatech.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dapatech.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call